Elliot Ehrich, SVP, R&D & CMO, Alkermes, Inc at Alkermes plc. (ALKS), sold 2,378 shares at $44.49 ($106K) on 2014-05-22, disclosed to the SEC on 2014-05-23.
Scheduled sale ($106k) by SVP, R&D & CMO, Alkermes, Inc under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALKS | SELL | 2017-02-16 | $1.2M | — | Filing → |
| ALKS | SELL | 2017-01-18 | $1.3M | — | Filing → |
| ALKS | SELL | 2017-01-06 | $618K | — | Filing → |